Cargando…

A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease

BACKGROUND: Infliximab is effective in inducing and maintaining remission in patients with Crohn’s disease (CD), but primary non-response (PNR) occurs in 10-30% of cases. We investigated whether serum biomarkers are effective in predicting PNR in patients with CD. METHODS: From January 2016 to April...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Li, Chen, Rirong, Zhang, Yingfan, Zhou, Gaoshi, Chen, Baili, Zeng, Zhirong, Chen, Minhu, Zhang, Shenghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339550/ https://www.ncbi.nlm.nih.gov/pubmed/34367126 http://dx.doi.org/10.3389/fimmu.2021.646673

Ejemplares similares

Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal
por: Chen, Rirong, et al.
Publicado: (2023)

Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
por: Zhou, Gaoshi, et al.
Publicado: (2022)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease
por: Chen, Peng, et al.
Publicado: (2021)

Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease
por: Zhuang, Xiaojun, et al.
Publicado: (2022)

Prealbumin and Retinol-Binding Protein 4: The Promising Inflammatory Biomarkers for Identifying Endoscopic Remission in Crohn’s Disease
por: Chen, Rirong, et al.
Publicado: (2021)

Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease
por: Chen, Rirong, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn’s disease patients with isolated anastomotic lesions
por: Chen, Rirong, et al.
Publicado: (2023)

Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
por: Chen, Rirong, et al.
Publicado: (2023)

Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqin, et al.
Publicado: (2020)

Correction to: Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqing, et al.
Publicado: (2020)

Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation
por: Chen, Rirong, et al.
Publicado: (2022)

A New Model Based on 25-Hydroxyvitamin D3 for Predicting Active Crohn's Disease in Chinese Patients
por: Lin, Sinan, et al.
Publicado: (2018)

Mucosal Healing Is Associated With the Reduced Disabling Disease in Crohn's Disease
por: Huang, Shanshan, et al.
Publicado: (2019)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
por: Li, Tong, et al.
Publicado: (2020)

Clinical Significance of Novel Neutrophil-Based Biomarkers in the Diagnosis and Prediction of Response to Infliximab Therapy in Crohn’s Disease
por: Zhou, Zhou, et al.
Publicado: (2022)

Tripartite motif family proteins in inflammatory bowel disease: Mechanisms and potential for interventions
por: Chen, Rirong, et al.
Publicado: (2022)

Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
por: Huang, Shanshan, et al.
Publicado: (2023)

Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn’s Disease
por: Zhao, Yue, et al.
Publicado: (2020)

Metabolomics facilitate the personalized management in inflammatory bowel disease
por: Chen, Rirong, et al.
Publicado: (2021)

Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease
por: Wang, Huiling, et al.
Publicado: (2016)

Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis
por: Chen, Rirong, et al.
Publicado: (2023)

Fecal lactoferrin early predicts long‐term outcomes in ulcerative colitis: A post‐hoc analysis of the UNIFI and PURSUIT trials
por: Chen, Rirong, et al.
Publicado: (2023)

A nomogram incorporating ileal and anastomotic lesions separately to predict the long-term outcome of Crohn’s disease after ileocolonic resection
por: Xiong, Shanshan, et al.
Publicado: (2023)

Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3
por: Li, Manying, et al.
Publicado: (2017)

Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease
por: Xie, Zhuo, et al.
Publicado: (2021)

Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets
por: Tie, Yizhe, et al.
Publicado: (2023)

Early transmural healing and its predictors assessed by magnetic resonance enterography in patients with Crohn’s disease receiving ustekinumab
por: Zhou, Longyuan, et al.
Publicado: (2023)

Risk factors and long-term outcome of disease extent progression in Asian patients with ulcerative colitis: a retrospective cohort study
por: Qiu, Yun, et al.
Publicado: (2019)

Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease
por: Ye, Chenglin, et al.
Publicado: (2022)

Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease
por: Choi, So Yoon, et al.
Publicado: (2023)

Nomogram to predict primary non-response to infliximab in patients with Crohn’s disease: a multicenter study
por: Ye, Xiao-Qi, et al.
Publicado: (2020)

Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area
por: Xu, Shu, et al.
Publicado: (2020)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
por: Lin, Lihui, et al.
Publicado: (2020)

Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice
por: Lin, Lihui, et al.
Publicado: (2022)

A Novel Nomogram Combining Mucus Barrier Index for Predicting Treatment Failures in Ulcerative Colitis
por: Wang, Ying, et al.
Publicado: (2023)

A Novel Radiomics Nomogram for the Prediction of Secondary Loss of Response to Infliximab in Crohn’s Disease
por: Chen, Yueying, et al.
Publicado: (2021)

Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report
por: Oh, Shin Ju, et al.
Publicado: (2022)

Development and Validation of an Interleukin-6 Nomogram to Predict Primary Non-response to Infliximab in Crohn’s Disease Patients
por: Chen, Yueying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6trf61nhu51tpn5hutecp5b23e